Clinical Trial Update: A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral dydrogesterone 30 mg daily to intravaginal micronized progesterone 600 mg daily for luteal support in IVF; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Infertility

Drugs mentioned

• Dydrogesterone (dydrogesterone)
• intravaginal micronized progesterone capsules (progesterone)

Snippet

Sponsor: Abbott | Conditions: Female Infertility | Phase 3 | Status: COMPLETED | Results posted: 2018-01-02